A comparison of heath-related quality of life in IPF and systemic sclerosis-related ILD

T. Sjåheim (Oslo, Norway), A. Hoffman-Vold (Oslo, Norway), T. Eagan (Bergen, Norway), A. Hovden (Asker, Norway), M. Lund (Oslo, Norway), G. Bjerke (Lørenskog, Norway), T. Jonassen (Bergen, Norway), O. Johansen (Asker, Norway), M. Durheim (Oslo, Norway)

Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Session: Assessment and management of immune-mediated interstitial lung diseases
Session type: Thematic Poster
Number: 4735
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Sjåheim (Oslo, Norway), A. Hoffman-Vold (Oslo, Norway), T. Eagan (Bergen, Norway), A. Hovden (Asker, Norway), M. Lund (Oslo, Norway), G. Bjerke (Lørenskog, Norway), T. Jonassen (Bergen, Norway), O. Johansen (Asker, Norway), M. Durheim (Oslo, Norway). A comparison of heath-related quality of life in IPF and systemic sclerosis-related ILD. 4735

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The relationship between GAP stage and quality of life in IPF and systemic sclerosis-related ILD is diagnosis-dependent
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018


The effect of pulmonary rehabilitation on health-related quality of life in patients with pulmonary sarcoidosis
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018




Health-related quality of life in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


Dyspnoa and health-related quality of life in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 570s
Year: 2006

Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

Assessment of quality of life of bronchiectasis patients associated with asthma and COPD.
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019




Is there a relationship between quality of life and exercise performance in idiopathic pulmonary fibrosis (IPF)?
Source: Eur Respir J 2007; 30: Suppl. 51, 577s
Year: 2007

Health-related quality of life development in IPF versus other ILD – the HILDA study
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019

Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019
Year: 2019



Frequency of bronchiectasis in patients with COPD and effects on quality of life
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009


Quality of life (HQoL) and well-being in patients with idiopathic pulmonary fibrosis (IPF): the role of portable oxygen
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

The association between functional and HRQOL (K-BILD) outcome measures in IPF and other fibrotic ILDs
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Predictors of health-related quality of life in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 66s
Year: 2006

Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year
Source: Eur Respir J 2010; 35: 1022-1030
Year: 2010



Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)
Source: Eur Respir J 2010; 35: 118-123
Year: 2010



Psychological predictors of health-related quality of life of interstitial lung disease patients.
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019

Detection of quality of life with COPD assessment test in chronic obstructive pulmonary disease and effect of dyspnea on disease-specific quality of life in these patients
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012

Severity of disease and health-related quality of life in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 513s
Year: 2005

Predictors of quality of life in patients with interstitial lung disease
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009